This webinar featured experts Dr. Joe Romano (NWJ Group/CAMI) and Dr. Jim Turpin (NIAID) who provided updates on the state of multipurpose prevention technologies (MPTs) research, the pipeline and potential manufacturing and regulatory pathways. MPTs are being developed to simultaneously prevent unintended pregnancy and protect against HIV and other sexually transmitted infections.Click to access the webinar slides and recording.
MPT Product Development & Regulatory Issues 101
GPP Overview Presentation
An AVAC PowerPoint presentation from February 2012 outlining basic information about the Good Participatory Practice guidelines including history of development, structure, and participatory practices.
GPP Training Curriculum Overview
A short overview of AVAC’s Good Participatory Practice (GPP) Training Curriculum, explaining to potential trainers how to use training components, including sessions. It links users to sessions and sample agendas to help plan a GPP training.
GPP Training Session 1: Introduction to GPP training and pre-test
Training Session #1 from AVAC’s Good Participatory Practice (GPP) Training Curriculum. It provides instructions to a GPP trainer for conducting an introduction session and pre-test in a GPP training workshop.
GPP Training Session 2: Agree or disagree
Training Session #2 from AVAC’s Good Participatory Practice (GPP) Training Curriculum. It provides instructions to a GPP trainer for conducting an a session which leads participants through a series of debates about fundamental GPP concepts.
GPP Training Session 3: GPP principles bingo
Training Session #3 from AVAC’s Good Participatory Practice (GPP) Training Curriculum. It provides instructions to a GPP trainer for conducting a session focused on the GPP principles from Section 2 of the GPP Guidelines.
GPP Training Session 4: Find your match
Training Session #4 from AVAC’s Good Participatory Practice (GPP) Training Curriculum. It provides instructions to a GPP trainer for conducting a session where participants learn the definitions of the 16 topic areas from Section 3 of the GPP Guidelines.
Female-Initiated HIV Prevention: What will we learn from upcoming trials?
A 2007 document developed in anticipation of data from the Carraguard microbicide and MIRA diaphragm trials of women-initiated prevention strategies. It contains explanations of trial design and possible outcomes.
An Action Agenda to End AIDS: Critical actions from 2012-2016 to begin to end the HIV/AIDS pandemic
Released at AIDS 2012, this report lays out a plan for beginning to end HIV/AIDS. It includes clear time-bound outcome targets, as well as the responsibilities of different stakeholders to achieve these targets.
Trials of Intermittent Dosing of Pre-Exposure Prophylaxis (PrEP): Summary from an AVAC think tank
Four-page summary of 2008 meeting on possibilities for intermittent PrEP research.